Literature DB >> 25666664

Shared clonality in distinctive lesions of lymphomatoid papulosis and mycosis fungoides occurring in the same patients suggests a common origin.

Maria M de la Garza Bravo1, Keyur P Patel2, Sanam Loghavi2, Jonathan L Curry3, Carlos A Torres Cabala3, Ronald C Cason2, Pamela Gangar4, Victor G Prieto3, L Jeffrey Medeiros2, Madeleine Duvic4, Michael T Tetzlaff5.   

Abstract

Lymphomatoid papulosis (LyP) lies within the spectrum of primary cutaneous CD30-positive lymphoproliferative disorders. Approximately 10% to 15% of patients with LyP develop other lymphomas, most commonly mycosis fungoides (MF), suggesting a biological relationship between these distinctive diseases. Here, we describe the clinical and histopathologic features of 11 patients who had both LyP and MF, including a total of 30 biopsy specimens (14 LyP and 16 MF). Clinically, LyP lesions were characterized by clustered papules undergoing spontaneous regression and were classified as type A (n = 11), type C (n = 2), or type D (n = 1). All cases of MF were characterized clinically by patch/plaque disease, were stage I or II at the time of diagnosis, and consisted of a CD4-predominant epidermotropic T-cell infiltrate. We used polymerase chain reaction-based methods to assess the TCR-β chain (TCRB) and TCR-γ chain (TCRG) in both LyP and MF lesions of all patients. Monoclonal TCR gene rearrangements were detected in 13 LyP lesions from 10 of 11 patients and in 14 MF lesions from 10 of 11 patients. All 10 patients in whom their skin lesions carried monoclonal TCR gene rearrangements exhibited overlapping clones in both their LyP and MF lesions; additional non-overlapping clones were identified in 3 LyP lesions from 2 patients and 1 MF lesion from another patient. The demonstration of shared monoclonal T-cell receptor gene rearrangements in LyP and MF lesions in almost all patients suggests a common origin between these distinctive clinicopathological diseases.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD30; Lymphomatoid papulosis; Mycosis fungoides; Shared clonality; TCR-PCR

Mesh:

Year:  2014        PMID: 25666664     DOI: 10.1016/j.humpath.2014.12.008

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  7 in total

Review 1.  Cutaneous T-cell Lymphoma.

Authors:  Melissa Pulitzer
Journal:  Clin Lab Med       Date:  2017-09       Impact factor: 1.935

Review 2.  Recent advances in cutaneous lymphoma-implications for current and future classifications.

Authors:  J R Goodlad; L Cerroni; S H Swerdlow
Journal:  Virchows Arch       Date:  2022-10-24       Impact factor: 4.535

3.  Frequency and Risk Factors for Associated Lymphomas in Patients With Lymphomatoid Papulosis.

Authors:  Nadège Cordel; Benoît Tressières; Michel D'Incan; Laurent Machet; Florent Grange; Éric Estève; Sophie Dalac; Saskia Ingen-Housz-Oro; Martine Bagot; Marie Beylot-Barry; Pascal Joly
Journal:  Oncologist       Date:  2015-12-14

4.  Biological and clinical significance of tryptophan-catabolizing enzymes in cutaneous T-cell lymphomas.

Authors:  Pilvi Maliniemi; Kirsi Laukkanen; Liisa Väkevä; Katja Dettmer; Tuomas Lipsanen; Leila Jeskanen; Alban Bessede; Peter J Oefner; Marshall E Kadin; Annamari Ranki
Journal:  Oncoimmunology       Date:  2017-02-10       Impact factor: 8.110

Review 5.  CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies.

Authors:  Lucia Prieto-Torres; Socorro M Rodriguez-Pinilla; Arantza Onaindia; Mariano Ara; Luis Requena; Miguel Á Piris
Journal:  Haematologica       Date:  2019-01-10       Impact factor: 9.941

Review 6.  An Update on Molecular Biology of Cutaneous T Cell Lymphoma.

Authors:  Ritika Walia; Cecilia C S Yeung
Journal:  Front Oncol       Date:  2020-01-22       Impact factor: 6.244

7.  Oncogenic Mutations and Gene Fusions in CD30-Positive Lymphoproliferations and Clonally Related Mycosis Fungoides Occurring in the Same Patients.

Authors:  Marion Wobser; Sabine Roth; Silke Appenzeller; Hermann Kneitz; Matthias Goebeler; Eva Geissinger; Andreas Rosenwald; Katja Maurus
Journal:  JID Innov       Date:  2021-06-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.